OPANA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Opana, and when can generic versions of Opana launch?
Opana is a drug marketed by Endo Pharms and Endo Operations and is included in four NDAs. There are five patents protecting this drug.
The generic ingredient in OPANA is oxymorphone hydrochloride. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the oxymorphone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Opana
A generic version of OPANA was approved as oxymorphone hydrochloride by IMPAX LABS on June 14th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OPANA?
- What are the global sales for OPANA?
- What is Average Wholesale Price for OPANA?
Summary for OPANA
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 30 |
| Patent Applications: | 4,756 |
| Drug Prices: | Drug price information for OPANA |
| What excipients (inactive ingredients) are in OPANA? | OPANA excipients list |
| DailyMed Link: | OPANA at DailyMed |
US Patents and Regulatory Information for OPANA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-005 | Dec 9, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-003 | Dec 9, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-007 | Dec 9, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
